Description: Trajenta 5 mg tablets are used to manage type 2 diabetes mellitus. The active ingredient, linagliptin, is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps control blood sugar levels by increasing insulin release and decreasing glucose production.
Ingredients:
-
Active Ingredient: Linagliptin 5 mg
-
Other Ingredients:
- Lactose monohydrate
- Microcrystalline cellulose
- Sodium starch glycolate
- Magnesium stearate
- Hydroxypropyl methylcellulose
- Titanium dioxide
- Color additives (as per product specification)
Usage Instructions:
-
Dosage: The recommended dose is one tablet (5 mg) once daily.
-
Frequency: Once daily.
-
Special Considerations:
- Can be taken with or without food.
- Take at the same time each day for consistency.
- Follow any additional instructions provided by your healthcare provider, especially if combined with other antidiabetic medications.
Benefits:
-
Effective Blood Sugar Control: Helps regulate blood sugar levels in people with type 2 diabetes.
-
Convenient Dosing: Once-daily dosing simplifies the treatment regimen.
-
Complementary Therapy: Can be used alone or in combination with other antidiabetic medications for better blood glucose management.
Precautions:
-
Contraindications: Not recommended for individuals with a known hypersensitivity to linagliptin or other DPP-4 inhibitors.
-
Side Effects: Possible side effects include upper respiratory tract infections, headache, and gastrointestinal symptoms. Rare but serious side effects may include pancreatitis.
-
Warnings:
- Monitor for signs of pancreatitis, such as severe abdominal pain.
- Inform your healthcare provider of all other medications and health conditions, including any history of kidney issues or type 1 diabetes.
Storage Instructions:
- Store at room temperature, between 15°C and 30°C (59°F and 86°F).
- Keep away from direct sunlight and moisture.
- Keep out of reach of children.
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
